Welcome to the e-CCO Library!

How much can we streamline GRADE process - USA vs ECCO perspectives / Do we need multiple sets of international (and national) guidelines? (Tandem Talk)
Year: 2021
Source: 2nd Guideline Methodology and GRADE Workshop
Authors: David Rubin, Timothy Raine
Created: Friday, 1 October 2021, 12:41 PM
Summary content

To review how to manage resources when writing GRADE guidelines
To review the pros and cons of universal guidelines

How the adult's clinic takes care of the young addult
Year: 2022
Source: 16th N-ECCO Network Meeting
Authors: James Lindsay
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

1) Highlight differences in disease presenting in adolescence compared to adulthood
2) Discuss the concept of transition vs transfer and the risks
3) Review the options available for transition and tools used to measure progress
4) Discuss guidelines

How the gut speaks to the liver: Novel insights from PSC pathogenesis
Year: 2018
Source: ECCO'18 Vienna
Authors: Tilg Herbert
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
How to Apply for and Secure EU Funding for Collaborative IBD Research Projects
Year: 2016
Source: JCC: Volume 10, Issue 3, 2016
Authors: Jack Satsangi, Olivier Kitten, Marcela Chavez, Rahul Kalla Nadege Prel, Marie-Alice Meuwis, Stephanie Scott, Illaria Bonetti, Nicholas T. Ventham, Edouard Louis
Created: Friday, 22 February 2019, 11:01 AM by ECCO Administrator

The European Union offers opportunities for high-level of funding of collaborative European research. Calls are regularly published: after the end of the FP7 funding programme the new round of Horizon 2020 calls started in 2015. Several topics are relevant to inflammatory bowel disease (IBD) challenges, including chronic disease management, biomarker discovery and new treatments developments. The aim of this Viewpoint article is to describe the new Horizon 2020 instrument and the project submission procedures, and to highlight these through the description of tips and tricks, taking advantage of four examples of successful projects in the field of IBD: the SADEL, IBD-BIOM, IBD Character and BIOCYCLE projects.

How to choose between treatment modalities?
Year: 2018
Source: 4th Basic ECCO: EduCational Course for Industry
Authors: Baert Filip
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
How to choose between treatment modalities? Treatment target and individualised treatment options
Year: 2020
Source: 5th Basic ECCO: EduCational COurse for Industry
Authors: Séverine Vermeire
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
How to communicate risks of disease or treatment with a patient?
Year: 2014
Source: Talking Heads
Authors: Marcus Harbord, Peter Irving
Created: Friday, 22 February 2019, 4:41 PM by ECCO Administrator
Last Modified: Friday, 13 January 2023, 12:27 PM by ECCO Administrator
How to conduct the data collection?
Year: 2022
Source: 7th N-ECCO Research Forum
Authors: Wladyslawa Czuber-Dochan
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

Educational objectives:
1. To understand the different methods of data collection for different study designs e.g qualitative, quantitative, mixed methods
2. To emphasise the role of different types of data collection methods e.g. interview, observation, survey, etc
3. To empasise practical issues to consider when data collecting 

How to deal with an IBD resection specimen
Year: 2019
Source: 4th H-ECCO IBD Masterclass
Authors: Monika Tripathi
Created: Tuesday, 28 May 2019, 3:32 PM
Differential diagnosis, Histology
Files: 1
How to develop guidelines
Year: 2018
Source: 5th N-ECCO Research Forum
Authors: Kemp Karen
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
How to diagnose and evaluate a new IBD case?
Year: 2021
Source: 1st ECCO Postgraduate Course in IBD
Authors: Laurent Peyrin-Biroulet
Created: Friday, 1 October 2021, 12:41 PM
Summary content

1. appropriate assessment
2. risk factors

How to diagnose and evaluate a new IBD case?
Year: 2022
Source: 2nd ECCO Postgraduate Course in IBD
Authors: Laurent Peyrin-Biroulet
Created: Tuesday, 24 May 2022, 8:13 PM
How to implement biosimilars
Year: 2019
Source: 13th N-ECCO Network Meeting
Authors: Kay Greveson
Created: Tuesday, 28 May 2019, 3:32 PM
Biosimilars, Patient choice
Files: 1
How to maximise safety? Cancer surveillance
Year: 2020
Source: 5th Basic ECCO: EduCational COurse for Industry
Authors: Laurent Beaugerie
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
How to monitor activity in Crohn's Disease
Year: 2019
Source: 6th ECCO-ESGAR Ultrasound Workshop - Advanced
Authors: Torsten Kucharzik
Created: Wednesday, 5 June 2019, 9:01 PM
How to monitor activity in Crohn's Disease
Year: 2019
Source: 6th ECCO-ESGAR Ultrasound Workshop - Advanced
Authors: Torsten Kucharzik
Created: Tuesday, 28 May 2019, 3:32 PM
Ultrasound
Files: 1
How to optimise recruitment to clinical trials in IBD
Year: 2017
Source: 2nd School for Clinical Trialists
Authors: Lees C.
Last Modified: Wednesday, 15 March 2017, 4:30 PM by Vesna Babaja
Files: 1
How to optimise the old school IBD Meds?
Year: 2021
Source: 1st ECCO Postgraduate Course in IBD
Authors: Shomron Ben-Horin
Created: Friday, 1 October 2021, 12:41 PM
Summary content

 In this talk we will discuss simple yet often overlooked pearls and tips to get the most of old-school medications, focusing on thiopurines and 5ASA. We will examine which combination of topical and oral 5ASA is best in each clinical scenario, discuss the role of compliance, how to optimize technical aspects of rectal agents, desensitization and factors not to be overlooked which may contribute to recalcitrant IBD. We will also explore metabolite testing for thiopurines in clinical practice and the evidence backing its use for maintenance monotherapy 

How to optimise the old school IBD Meds?
Year: 2022
Source: 2nd ECCO Postgraduate Course in IBD
Authors: Shomron Ben-Horin
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

 In this talk we will discuss simple yet often overlooked pearls and tips to get the most of old-school medications, focusing on thiopurines and 5ASA. We will examine which combination of topical and oral 5ASA is best in each clinical scenario, discuss the role of compliance, how to optimize technical aspects of rectal agents, desensitization and factors not to be overlooked which may contribute to recalcitrant IBD. We will also explore metabolite testing for thiopurines in clinical practice and the evidence backing its use for maintenance monotherapy 

How to perform a scientifically sound literature research - the new ECCO SOP
Year: 2019
Source: 1st Guideline Methodology and GRADE Workshop
Authors: Joana Torres
Created: Wednesday, 5 June 2019, 9:01 PM